Tektrotide Whole Body

  • Preparation for scan is required. Please contact our practice.

Patients are injected with a radioactive tracer (Tc99m Tektrotide). The tracer is taken up by somatostatin receptors in carcinoid tumours (malignant tumours, usually in the digestive tract), multiple myelomas (bone marrow tumours), and endocrine tumours (tumours in the glands). The radioactive Tektrotide appears on the scan, allowing the diagnosis of tumours.

Used to diagnose:


Phone our practice

How to book

Patients will need to be referred to Nuclear Med by a referring doctor. Patients must select the specific scan/study required by their referring doctor and book an appointment at the most convenient location.


  • Medical aid authorisation (referring doctor to provide patient with specific ICD 10 code for medical aid authorisation)
  • Referring doctor’s name and practice number
  • Newly diagnosed oncology patients may need to register for oncology (referring doctor to facilitate registration)